ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NDRA ENDRA Life Sciences Inc

0.2892
0.0091 (3.25%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 301,267
Bid Price 0.227
Ask Price 0.3352
News (1)
Day High 0.31

Low
0.221

52 Week Range

High
2.77

Day Low 0.2621
Share Name Share Symbol Market Stock Type
ENDRA Life Sciences Inc NDRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0091 3.25% 0.2892 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.291 0.2621 0.31 0.269 0.2801
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
616 301,267 US$ 0.2887719 US$ 86,997 - 0.221 - 2.77
Last Trade Type Quantity Price Currency
18:39:45 6 US$ 0.2952 USD

ENDRA Life Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.28M 8.45M - 0 -10.06M -1.19 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ENDRA Life Sciences News

Date Time Source News Article
5/31/202415:21Edgar (US Regulatory)Form S-1/A - General form for registration of securities..
5/20/202407:05Edgar (US Regulatory)Form 8-K - Current report
5/20/202407:00Business WireENDRA Provides Update Following In-person Meeting with FDA
5/14/202415:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202415:17Edgar (US Regulatory)Form 8-K - Current report
5/14/202415:05Business WireENDRA Life Sciences Reports First Quarter 2024 Financial..
5/10/202416:18Edgar (US Regulatory)Form 8-K - Current report
5/10/202416:17Edgar (US Regulatory)Form S-1/A - General form for registration of securities..
5/07/202407:00Business WireENDRA Life Sciences to Report First Quarter 2024 Financial..
5/02/202407:00Business WireENDRA Life Sciences Strengthens Intellectual Property with..
3/28/202415:05Business WireENDRA Life Sciences Reports Fourth Quarter and Full Year..
3/21/202407:00Business WireENDRA Life Sciences to Report Fourth Quarter 2023 Financial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NDRA Message Board. Create One! See More Posts on NDRA Message Board See More Message Board Posts

Historical NDRA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2850.330.25060.2794325153,1060.00421.47%
1 Month0.3440.3440.25060.2970517119,034-0.0548-15.93%
3 Months1.081.240.2210.5428324191,670-0.7908-73.22%
6 Months0.972.770.2210.919656154,944-0.6808-70.19%
1 Year1.602.770.2211.03117,985-1.31-81.93%
3 Years42.6048.800.2219.70430,839-42.31-99.32%
5 Years22.4062.000.22123.75521,582-22.11-98.71%

ENDRA Life Sciences Description

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.